Investors & Media
UPCOMING EVENTS
ACAAI 2022 Poster 006
Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use:
A Patient/Caregiver Survey
Download >
ACAAI 2022 Poster 008
Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms:
Results of a Patient/Caregiver Survey
Download >
ACAAI 2022 Poster 236
Pharmacokinetics and Pharmacodynamics of ARS-1 (neffy® Nasal Spray)
and Manual Intramuscular Injection in Subjects With/Without Allergic Rhinitis
Download >
ACAAI 2022 Poster 237
ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic
Differences and Differential Affinities for Adrenergic Receptors
Download >
ACAAI 2022 Poster 238
Pharmacokinetics/Pharmacodynamics After Single and Repeat Administration of
ARS-1 (neffy® Nasal Spray), Epinephrine Auto-Injector, and Manual Intramuscular Injection
Download >
ACAAI 2020 Poster 008
Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms:
Results of a Patient/Caregiver Survey
Download >
AAAAI 2022 Poster 007
Self-Administration of Intranasal Epinephrine (neffy ) Using the Aptar Unit Dose System
Compared to EpiPen and Symjepi
Download >
AAAAI 2022 Poster 008
Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors
Download >
AAAAI 2022 Poster 009
The Pharmacokinetic and Pharmacodynamic Properties of Intranasal Epinephrine Spray (neffy )
Compared to Manual Intramuscular Administration, EpiPen, and Symjepi: an Integrated Analysis
Download >
AAAAI 2020 Poster 022
Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions
Download >
ACAAI 2022 Poster 006
Time Before Use of Epinephrine Injectable Devices and Triggers Driving Use:
A Patient/Caregiver Survey
Download >
ACAAI 2022 Poster 008
Epinephrine Via Needle-Free Device Would Be Administered Faster After Symptoms:
Results of a Patient/Caregiver Survey
Download >
ACAAI 2022 Poster 236
Pharmacokinetics and Pharmacodynamics of ARS-1 (neffy® Nasal Spray)
and Manual Intramuscular Injection in Subjects With/Without Allergic Rhinitis
Download >
ACAAI 2022 Poster 237
ARS-1 (neffy® Nasal Spray) and Intramuscular Injection: Pharmacokinetic/Pharmacodynamic
Differences and Differential Affinities for Adrenergic Receptors
Download >
ACAAI 2022 Poster 238
Pharmacokinetics/Pharmacodynamics After Single and Repeat Administration of
ARS-1 (neffy® Nasal Spray), Epinephrine Auto-Injector, and Manual Intramuscular Injection
Download >
AAAAI 2022 Poster 007
Self-Administration of Intranasal Epinephrine (neffy ) Using the Aptar Unit Dose System
Compared to EpiPen and Symjepi
Download >
AAAAI 2022 Poster 008
Comparison of Pharmacokinetic Parameters and Intra-Blood Vessel Injection Rates Between Manual Intramuscular Injection and Epinephrine Auto-Injectors
Download >
AAAAI 2022 Poster 009
The Pharmacokinetic and Pharmacodynamic Properties of Intranasal Epinephrine Spray (neffy )
Compared to Manual Intramuscular Administration, EpiPen, and Symjepi: an Integrated Analysis
Download >
AAAAI 2020 Poster 022
Learning from Epinephrine Treatment Characteristics Among Patients with Severe Allergic Reactions
Download >